[Use of etretinate (RO-10-9359) in intermittent doses and follow-up for 1 year in patients with psoriasis. Final report]

Autor:	L, Domínguez Soto, M T, Hokyo Tomoka, J J, Armas
Rok vydání:	1984
Předmět:	Adult Male Adolescent Etretinate Administration Oral Drug Evaluation Humans Psoriasis Female Middle Aged Aged Follow-Up Studies
Zdroj:	Medicina cutanea ibero-latino-americana. 12(1)
ISSN:	0210-5187
Popis:	p6e results of the treatment of 21 cases of psoriasis with etretinate are reported. The initial doses was 1 mg./Kg./daily for 8 weeks and, after control of the disease, minimal doses alternative with placebo administration. This method permits to obtain good results with minimal side effects.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::0e72bc61fdca512c6637c72e062c7e6a https://pubmed.ncbi.nlm.nih.gov/6376979 Zobrazit plný text záznamu